Acesso livre
Acesso livre

Covid-19

Estudo RECOVERY | Baricitinibe em pacientes hospitalizados com COVID-19.

5 Ago, 2022 | 16:50h

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis – The Lancet

Comentário convidado: Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality – The Lancet

Conteúdos relacionados:

Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial – medRxiv

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial – The Lancet Respiratory Medicine

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis – medRxiv

WHO recommends two new drugs to treat COVID-19 – World Health Organization

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial – The Lancet Respiratory Medicine

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 – New England Journal of Medicine

 

Comentário no Twitter

Sob licença de Creative Commons Attribution (CC BY 4.0)

 


Revisão sistemática | Testes rápidos de antígeno para diagnóstico de infecção por SARS-CoV-2.

1 Ago, 2022 | 15:23h

Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection – Cochrane Library

Resumo: How accurate are rapid antigen tests for diagnosing COVID-19? – Cochrane Library

 


Estudo randomizado | Tixagevimabe-cilgavimabe para tratamento de pacientes internados com COVID-19.

18 Jul, 2022 | 13:36h

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial – The Lancet Respiratory Medicine

Comentário: The potential of tixagevimab–cilgavimab for treating hospitalized COVID-19 patients – News Medical

Conteúdos relacionados:

Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial – The Lancet Respiratory Medicine

Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19 – New England Journal of Medicine

 

Comentário no Twitter

 


Revisão | Infecções fúngicas respiratórias invasivas em pacientes críticos com COVID-19.

18 Jul, 2022 | 13:33h

Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients – Journal of Fungi

 


FDA autoriza o uso emergencial da vacina Novavax contra COVID-19.

18 Jul, 2022 | 13:01h

Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted – U.S. Food & Drug Administration

Comentários:

FDA authorizes Novavax Covid vaccine, in hopes the traditional shot will convince holdouts – STAT

US regulators OK new COVID-19 shot option from Novavax – Associated Press

 


Estudo de coorte de abrangência nacional | Segurança dos esquemas de vacinação primária heteróloga e reforços com vacinas ChAdOx1-S e BNT162b2 ou mRNA-1273.

18 Jul, 2022 | 12:54h

Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study – The BMJ

 


Modelos de predição clínica para mortalidade em pacientes com Covid-19: validação externa e metanálise de dados individuais de participantes.

14 Jul, 2022 | 11:59h

Clinical prediction models for mortality in patients with covid-19: external validation and individual participant data meta-analysis – The BMJ

 


Perspectiva | Por que a BA.5 parece diferente: a mais recente onda de infecções é um teste para nossas prioridades relacionadas à pandemia.

13 Jul, 2022 | 12:29h

Why BA.5 Feels Different – The Atlantic

 


Nova mutação do coronavírus (BA.2.75) aumenta a preocupação na Índia e além.

13 Jul, 2022 | 12:28h

New coronavirus mutant raises concerns in India and beyond – Associated Press

 


M-A | Mudanças globais na atividade física de crianças e adolescentes durante a pandemia de COVID-19.

13 Jul, 2022 | 12:24h

Global Changes in Child and Adolescent Physical Activity During the COVID-19 Pandemic: A Systematic Review and Meta-analysis – JAMA Pediatrics (gratuito por tempo limitado)

 


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.